METRONIDAZOLE ROSEMONT 200MG/5ML ORAL SUSPENSION
Country: Cyprus
Language: Greek
Source: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας
Patient Information leaflet
(PIL)
16-03-2018
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
METRONIDAZOLE BENZOATE
Available from:
ROSEMONT PHARMACEUTICALS LTD (0000003559) ROSEMOND HOUSE, YORKDALE INDUSTRIAL PARK, BRAITHWAITE STR., LEEDS , LS11 9XE
ATC code:
P01AB01
INN (International Name):
METRONIDAZOLE
Dosage:
200MG/5ML
Pharmaceutical form:
ORAL SUSPENSION
Composition:
METRONIDAZOLE BENZOATE (0013182893) 320MG
Administration route:
ORAL USE
Prescription type:
Ειδική άδεια άρθρο 126A
Therapeutic area:
METRONIDAZOLE
Product summary:
Νομικό καθεστώς: Με Ιατρική Συνταγή; 1 BOTTLE X 60ML (27S005001) 60 MILLILITRE - Αποσυρθέν - Με Ιατρική Συνταγή; 1 BOTTLE X 100ML (27S005002) 100 MILLILITRE - Εγκεκριμένο - Με Ιατρική Συνταγή; 1 BOTTLE X 125ML (27S005003) 125 MILLILITRE - Αποσυρθέν - Με Ιατρική Συνταγή; 1 BOTTLE X 150ML (27S005004) 150 MILLILITRE - Αποσυρθέν - Με Ιατρική Συνταγή
